Pain associated with prostaglandin E<sub>1</sub>‐containing intracavernosal injection medication is associated with poor erectile function recovery after radical prostatectomy
Incidence of pain is high in men with non-nerve sparing radical prostatectomy; older patient age, poorer nerve sparing, poor baseline erectile function, and the presence of penile pain with prostaglandin E1-containing intracavernosal injection medication, were predictive of poor erectile function recovery using phosphodiesterase-5 inhibitors at 24 months.
Authors
- Joseph Narus (ORCID: https://orcid.org/0000-0001-7403-6469)
- Billy H. Cordon (ORCID: https://orcid.org/0000-0002-8836-3687)
- John P. Mulhall (ORCID: https://orcid.org/0000-0001-5455-3047)
- Yanira Ortega
- Michael West
Institutions
- Memorial Sloan Kettering Cancer Center (US)
Publication Details
- Journal
- Andrology
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1111/andr.13784
- Citations
- 4
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 1.54
Funders
- Prostate Cancer Foundation
- Patient-Centered Outcomes Research Institute
- Memorial Sloan-Kettering Cancer Center
- National Institutes of Health
- Sidney Kimmel Center for Prostate and Urologic Cancers
- National Cancer Institute